Portfolio (Quarterly)
Guide ↗
PIER 88 INVESTMENT PARTNERS LLC
· CIK 0001697366| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | OKTA INC | — | 16,660,000.0 | $16.5M | 4.11% | -4.5M | -21.2% | $0.99 | — |
| 2 | — | HEWLETT PACKARD ENTERPRISE C 7.625 MAND CONV | — | 253,440.0 | $16.3M | 4.07% | -6K | -2.4% | $64.51 | — |
| 3 | — | BANK AMERICA CORP 7.25 PERCENTAGE CNV PFD L | — | 13,653.0 | $16.3M | 4.05% | -370.0 | -2.6% | $1191.56 | — |
| 4 | — | WELLS FARGO & CO PERP PFD CNV A | — | 13,580.0 | $15.7M | 3.90% | -402.0 | -2.9% | $1155.00 | — |
| 5 | — | SHIFT4 PMTS INC | — | 16,346,000.0 | $15.3M | 3.81% | -1.4M | -7.8% | $0.94 | — |
| 6 | — | VENTAS RLTY LTD PARTNERSHIP | — | 8,960,000.0 | $13.3M | 3.32% | -8.0M | -47.3% | $1.49 | — |
| 7 | — | KKR & CO INC 6.25 CON SER D | — | 235,810.0 | $9.5M | 2.36% | -89K | -27.3% | $40.22 | — |
| 8 | — | ARES MANAGEMENT CORPORATION 6.75 SE B PFD | — | 234,800.0 | $8.5M | 2.11% | -94K | -28.6% | $36.18 | — |
| 9 | — | AMERICAN WTR CAP CORP | — | 6,870,000.0 | $6.9M | 1.71% | -8.1M | -54.1% | $1.00 | — |
| 10 | — | APOLLO GLOBAL MGMT INC SER A MAND CNV | — | 104,700.0 | $6.1M | 1.52% | -67K | -39.1% | $58.46 | — |
| 11 | — | MICROCHIP TECHNOLOGY INC. DEP | — | 68,000.0 | $3.9M | 0.96% | -23K | -25.5% | $56.97 | — |
| 12 | ATI | ATI INC | Industrials | 18,000.0 | $2.6M | 0.65% | -23K | -56.0% | $145.46 | +38.4% |
| 13 | LGND | LIGAND PHARMACEUTICALS INC | Healthcare | 8,000.0 | $1.6M | 0.40% | -520.0 | -6.1% | $199.65 | +37.7% |
| 14 | — | NUTANIX INC | — | 1,620,000.0 | $1.5M | 0.36% | -47K | -2.8% | $0.90 | — |
| 15 | MPWR | MONOLITHIC PWR SYS INC | Technology | 1,200.0 | $1.3M | 0.33% | -150.0 | -11.1% | $1093.35 | +43.0% |
| 16 | NTRA | NATERA INC | Healthcare | 6,500.0 | $1.3M | 0.32% | -684.0 | -9.5% | $199.99 | +15.7% |
| 17 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 64,800.0 | $1.2M | 0.31% | -3K | -5.0% | $19.20 | +21.4% |
| 18 | — | MOOG INC | — | 4,200.0 | $1.2M | 0.31% | -17K | -80.0% | $292.64 | — |
| 19 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 19,000.0 | $1.2M | 0.31% | -280.0 | -1.4% | $64.63 | +6.1% |
| 20 | LSCC | LATTICE SEMICONDUCTOR CORP | Technology | 12,900.0 | $1.2M | 0.30% | -13K | -49.3% | $92.76 | +65.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
28.1%
Industrials
27.6%
Technology
25.5%
Real Estate
8.2%
Energy
3.8%
Basic Materials
2.5%
Utilities
2.3%
Consumer Cyclical
1.7%
Financial Services
0.4%